Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.4002
Delayed Data
As of Dec 09
 +0.0773 / +23.94%
Today’s Change
0.29
Today|||52-Week Range
1.31
-65.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues21.7M22.4M26.8M44.7M
 
 
 
 
 
Cost of Goods Sold11.5M12.1M14.6M21.4M
 
 
 
 
 
Depreciation And Amortization1.1M986.0K1.0M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income9.1M9.3M11.2M21.7M
 
 
 
 
 
General Expenses37.4M45.0M61.7M78.1M
 
 
 
 
 
Research And Development24.3M27.7M43.0M59.5M
 
 
 
 
 
Total Operating Expenses50.0M58.1M77.3M101.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.4M-35.7M-50.5M-56.4M
 
 
 
 
 
Extraordinary Credit0.000.000.00600.0K
 
 
Extraordinary Charge-1.7M0.000.000.00
 
 
Interest Expense On Debt54.0K5.0K0.000.00
 
 
 
Other Expenses0.000.00-1.0K-14.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.8M-35.4M-50.4M-55.7M
 
 
 
 
 
Preferred Dividend0.00-401.0K-3.7M-4.5M
 
 
 
 
Net Income-29.8M-35.4M-50.4M-55.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS120.4M161.6M182.6M216.3M
 
 
 
 
 
Shares To Calculate EPS Diluted120.4M161.6M182.6M216.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.22-$0.30-$0.28
 
 
 
 
 
EPS Diluted-$0.25-$0.22-$0.30-$0.28